ORI Updates

ORI found that Dr. Rahul Agrawal, former visiting fellow at the Center for Cancer Research, Laboratory of Pathology, Cancer Molecular Pathology Section, National Cancer Institute (NCI), NIH, engaged in research misconduct in research supported by the Intramural Research Program of NCI, NIH.

Alexander Runko, Ph.D., starting Aug. 4, will be the new Director of ORI’s Division of Investigative Oversight (DIO).

Adm. Brett P. Giroir, M.D., HHS Assistant Secretary for Health, announced today that Elisabeth Handley will join the Office of Research Integrity as the Interim Director.

Dr. Wanda Jones, who was ORI's Interim Director, has been permanently named as ORI's Deputy Director and will serve as Acting Director.

ORI found that William W. Cruikshank, Ph.D. (Respondent), former Professor of Medicine, Pulmonary Center, BU School of Medicine engaged in research misconduct in research supported by National Cancer Institute (NCI), National Institutes of Health (NIH).

ORI found that Edward J. Fox, Ph.D. (Respondent), former Acting Assistant Professor in the Department of Pathology, UW, engaged in research misconduct in research supported by National Cancer Institute (NCI), National Institutes of Health (NIH).

ORI has funding opportunity for research on research integrity and the responsible conduct of research. Deadline: May 8, 2019.

Co-organized with Northwestern University and Council of Graduate Schools, this conference provides a forum for senior institutional officials to openly discuss their roles for promoting research integrity and preventing misconduct. VPRs, Deans, and other senior officials are encouraged to join this very informative meeting. The event will be held in Chicago, IL on May 22-23, 2019.

ORI has a funding opportunity for grants to hold conferences on research integrity. Deadline April 26, 2019.

Creating a new member handbook may help to provide resources for professional growth and success within the lab.